Patents by Inventor Kulwant Kamboj

Kulwant Kamboj has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human antibodies against LPS derived from transgenic xenomouse
    Patent number: 9089557
    Abstract: The invention described herein provides for human antibodies produced in non-human animals that specifically bind to Pseudomonas aeruginosa Lipopolysaccharide (LPS). The invention further provides methods for making the antibodies in a non-human animal, expression of the antibodies in cell lines including hybridomas and recombinant host cell systems. Also provided are kits and pharmaceutical compositions comprising the antibodies and methods of treating or preventing pseudomonas infection by administering to a patient the pharmaceutical compositions described herein.
    Type: Grant
    Filed: March 3, 2015
    Date of Patent: July 28, 2015
    Assignee: Case Western Reserve University
    Inventors: John R. Schreiber, Kulwant Kamboj Kaur
  • HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE
    Publication number: 20150175680
    Abstract: The invention described herein provides for human antibodies produced in non-human animals that specifically bind to Pseudomanas aeruginosa Lipopolysaccharide (LPS). The invention further provides methods for making the antibodies in a non-human animal, expression of the antibodies in cell lines including hybridomas and recombinant host cell systems. Also provided are kits and pharmaceutical compositions comprising the antibodies and methods of treating or preventing pseudomonas infection by administering to a patient the pharmaceutical compositions described herein.
    Type: Application
    Filed: March 3, 2015
    Publication date: June 25, 2015
    Inventors: John R. SCHREIBER, Kulwant Kamboj KAUR
  • Human antibodies against LPS derived from transgenic xenomouse
    Patent number: 7972845
    Abstract: The invention described herein provides for human antibodies produced in non-human animals that specifically bind to Pseudomonas aeruginosa Lipopolysaccharide (LPS). The invention further provides methods for making the antibodies in a non-human animal, expression of the antibodies in cell lines including hybridomas and recombinant host cell systems. Also provided are kits and pharmaceutical compositions comprising the antibodies and methods of treating or preventing pseudomonas infection by administering to a patient the pharmaceutical compositions described herein.
    Type: Grant
    Filed: September 7, 2001
    Date of Patent: July 5, 2011
    Assignee: Case Western Reserve University
    Inventors: John R. Schreiber, Kulwant Kamboj
  • Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
    Publication number: 20040137001
    Abstract: The invention described herein provides for human antibodies produced in non-human animals that specifically bind to Pseudomonas aeruginosa Lipopolysaccharide (LPS). The invention further provides methods for making the antibodies in a non-human animal, expression of the antibodies in cell lines including hybridomas and recombinant host cell systems. Also provided are kits and pharmaceutical compositions comprising the antibodies and methods of treating or preventing pseudomonas infection by administering to a patient the pharmaceutical compositions described herein.
    Type: Application
    Filed: October 23, 2003
    Publication date: July 15, 2004
    Inventors: John R Schreiber, Kulwant Kamboj